10 November 2020
Hogan Lovells advises Novartis on Vedere Bio acquisition
Advising firms
Deal team
18 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Adam Golden Lead | Hogan Lovells | Partner | M&A | New York |
| Michael Szlamkowicz | Hogan Lovells | Partner | Private Equity & Funds | Not stated |
| Jeffrey Jay | Hogan Lovells | Senior associate | M&A | Not stated |
| Brittany Raway | Hogan Lovells | Senior associate | M&A | Not stated |
| Carin Carithers | Hogan Lovells | Partner | Tax, Pensions & Benefits | Not stated |
| Christine Lane | Hogan Lovells | Partner | Tax, Pensions & Benefits | Not stated |
| Kurt Lawson | Hogan Lovells | Partner | Tax, Pensions & Benefits | Not stated |
| William Ferreira | Hogan Lovells | Partner | Global Regulatory | Not stated |
| Susan Lee | Hogan Lovells | Partner | Global Regulatory | Not stated |
| Mike Applebaum | Hogan Lovells | Counsel | Not stated | Not stated |
| Tao Y Leung | Hogan Lovells | Counsel | Not stated | Not stated |
| Lauren Battaglia | Hogan Lovells | Senior associate | Not stated | Not stated |
| Steven Palyca | Hogan Lovells | Senior associate | Not stated | Not stated |
| David Mitchell | Hogan Lovells | Senior associate | Not stated | Not stated |
| David Steenburg | Hogan Lovells | Senior associate | Not stated | Not stated |
| Andrew Brandes | Hogan Lovells | Associate | Not stated | Not stated |
| Kate McGuigan | Hogan Lovells | Associate | Not stated | Not stated |
| Sarah Godwin | Hogan Lovells | Associate | Not stated | Not stated |
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- NovartisBuy-side
- Counterparties
- Vedere Bio (Sell-side)